Product Information
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.2268 per EA under NDC 72888022001. Its NADAC has been published 32 times since Feb 25, 2026.
FDA first approved this application on May 19, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB
benazepril hydrochloride and hydrochlorothiazideStrength
10; 12.5 mg/1; mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888022001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020033FDA Approved
5/19/1992
TE Code
AB
On Market Since
12/5/2024
Pharmacological Classes
Price Statistics
The NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has been published 32 times since Feb 25, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2268 per EA |
|---|---|
| All-time high | $0.2521 (Jul 15, 2026) |
| All-time low | $0.2239 (Apr 22, 2026) |
| 52-week high | $0.2521 |
| 52-week low | $0.2239 |
| Median price | $0.2430 |
| Average price | $0.2380 |
| Largest weekly change | +8.7% (May 20, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the benazepril hydrochloride and hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
benazepril hydrochloride and hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB, manufactured by Advagen Pharma Ltd., is $0.2268 per EA (NDC 72888022001), effective Sep 30, 2026.
How has the price of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has held within roughly two percent of its current level. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
Since Feb 25, 2026, the NADAC for BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB has ranged from a low of $0.2239 (Apr 22, 2026) to a high of $0.2521 (Jul 15, 2026), with a median of $0.2430 per EA.
Are there cheaper alternatives to BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB?
BENAZEPRIL-HYDROCHLOROTHIAZIDE 10-12.5 MG TAB (NDC 72888022001) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.